Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

By Drabick J.J.   Brandt B.L.   Moran E.E.   Saunders N.B.   Shoemaker D.R.   Zollinger W.D.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

By Holst J.   Feiring B.   Fuglesang J.E.   Hoiby E.A.   Nokleby H.   Aaberge I.S.   Rosenqvist E.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 734-737

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine

By Meyer Naess L.   Aarvak T.   Aase A.   Oftung F.   Hoiby E.A.   Sandin R.   Michaelsen T.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 754-764

Elsevier

Access to resources Recommend Favorite

Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

By Rouppe van der Voort E.   Schuller M.   Holst J.   de Vries P.   van der Ley P.   van den Dobbelsteen G.   Poolman J.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1334-1343

Elsevier

Access to resources Recommend Favorite